Visualization of Plasma and Tissue Binding Using Dose Fractions Parameter-Reference-Cited by-同舟云学术

Visualization of Plasma and Tissue Binding Using Dose Fractions Parameter

Published:2014-10-15 Issue: Volume: Page:n/a-n/a
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev. Res.

Author:

Svennebring Andreas¹

Affiliation:

1. Department of Pharmaceutical Biosciences; Division of Pharmaceutical Bioinformatics; Biomedical Centre; Uppsala University; Uppsala SE 751 24 Sweden

Publisher

Wiley

Subject

Drug Discovery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ddr.21226/fullpdf

Reference28 articles.

1. Effects of serum albumin and liver cytosol on CYP2C9- and CYP3A4-mediated drug metabolism;Baba;Drug Metab Pharmacokinet,2002

2. Changes in plasma protein binding have little clinical relevance;Benet;Clin Pharmacol Ther,2002

3. Effect of binding protein surface charge on palmitate uptake by hepatocyte suspensions;Burczynski;Br J Pharmacol,1997

4. Cytosolic fatty acid binding protein enhances rat hepatocyte [3H]palmitate uptake;Burczynski;Can J Physiol Pharmacol,1999

5. Hepatocyte [3H]-palmitate uptake: effect of albumin surface charge modification;Burczynski;Can J Physiol Pharmacol,2001

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The connection Between Plasma Protein Binding and Acute Toxicity as Determined by the LD50Value;Drug Development Research;2015-12-21

2. The usefulness of Øie–Tozer’s model in deriving pharmacokinetic changes in response to changes in the concentration of drug-binding plasma protein;Xenobiotica;2015-11-02

3. The impact of the concentration of drug binding plasma proteins on drug distribution according to Øie-Tozer’s model;Xenobiotica;2015-08-10

4. How to report and discuss ADME data in medicinal chemistry publications: in vitro data or in vivo extrapolations?;Future Medicinal Chemistry;2015-03

5. Investigation of the prerequisites for the optimization of specific plasma protein binding as a strategy for the reduction of first-pass hepatic metabolism;Xenobiotica;2014-11-03